BioNTech SE (BNTX) Income from Non-Controlling Interests (2018 - 2019)
BioNTech SE's (BNTX) quarterly Income from Non-Controlling Interests came in at $17710.2 in Q4 2019, down 87.26% year-on-year from $138973.0 in Q4 2018, and down 87.26% quarter-over-quarter from $138973.0 in Q4 2018.
BioNTech SE (BNTX) Income from Non-Controlling Interests (2018 - 2019) Analysis & Trends
BioNTech SE has disclosed Income from Non-Controlling Interests across 2 years of filings, most recently posting $17710.2 for Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 17,710.20 |
| Dec 31, 2018 | 138,973.00 |
| Sep 30, 2018 | -54,667.07 |